French Stock News

How Accor’s Recent Share Performance Frames Today’s Setup Accor (ENXTPA:AC) has seen its share price fall about 17% over the past month and about 15% over the past 3 months, putting the hotel group’s current valuation and fundamentals back in focus for investors. See our latest analysis for Accor. That recent 17% 1 month share price decline sits against a 1 year total shareholder return of about a 3% decline and a 3 year total shareholder return of about 48%. This suggests shorter term...

Recent share performance snapshot Compagnie Générale des Établissements Michelin Société en commandite par actions (ENXTPA:ML) has seen mixed recent share performance, with a small 1 day decline, a positive week, pressure over the past month, and gains over the past 3 months. See our latest analysis for Compagnie Générale des Établissements Michelin Société en commandite par actions. At a share price of €29.0, Michelin’s recent pattern shows short term weakness after a 30 day share price...

TotalEnergies and EDF have signed a 12 year contract to supply nuclear electricity to French industrial sites. The agreement is expected to cover around 60% of the electricity needs of TotalEnergies' refining and chemicals sites in France with nuclear power. CEO Patrick Pouyanné has indicated that the group will reassess its net zero plans given current global clean energy transition trends and EU 1.5°C expectations. For investors watching ENXTPA:TTE, this move comes with the share price at...

Before getting into the numbers, it helps to know why Thales might be on your radar, especially if you are asking whether the current share price still represents value or if most of the opportunity is already reflected in the market. Recently, Thales shares closed at €237.90, with returns of 1.2% year to date, 85.1% over 3 years and 203.1% over 5 years. Over the last 7 days and 30 days the shares showed declines of 1.8% and 6.1% respectively, which can shift how investors think about both...

Shareholders in Forsee Power S.A. ( EPA:ALFOR ) may be thrilled to learn that the analysts have just delivered a major...

It's been a mediocre week for Quadient S.A. ( EPA:QDT ) shareholders, with the stock dropping 11% to €11.24 in the week...

OVH Groupe (ENXTPA:OVH) has recently drawn investor attention after a period of mixed share performance, with modest gains over the month and past year contrasting with a weaker three year total return. See our latest analysis for OVH Groupe. The stock’s 90 day share price return of 22.57% and year to date share price return of 19.93%, alongside a 1 year total shareholder return of 20.50% but a 3 year total shareholder loss of 22.37%, suggest momentum has recently improved after a tougher...

Cegedim (ENXTPA:ALCGM) has reported its FY 2025 first half with revenue of €322.5 million, basic EPS of €0.09, and net income of €1.2 million, setting a mixed backdrop for investors weighing profitability against recent losses. The company has seen revenue move from €319.0 million in the first half of 2024 to €322.5 million in the latest half, while EPS shifted from €0.05 to €0.09 over the same period, with trailing 12 month figures still showing a loss of €14.2 million on €658.0 million of...

Recent performance snapshot for Arkema Arkema (ENXTPA:AKE) has drawn fresh attention after a mixed run for shareholders, with the stock showing a 4.5% gain over the past day but a 14.2% decline over the past year. Over the past week the share price return is 15.2%, while the past month shows a 3.4% decline and the past 3 months a 14.1% gain, leaving year-to-date performance at 11.2%. See our latest analysis for Arkema. With the share price at €58.2, Arkema has seen strong short term share...

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...

Valeo (ENXTPA:FR) is investing $225 million in a new manufacturing facility in Texas. The plant will produce central compute units for General Motors' software-defined vehicles. The project supports one of the largest orders in Valeo's history and expands its US footprint. For investors watching the auto technology space, this move places Valeo more firmly among the suppliers building the electronics behind software-defined vehicles. The Texas facility connects directly to Valeo's existing...

Dassault Aviation société anonyme (ENXTPA:AM) has drawn investor attention after recent trading left the shares around €310, with mixed returns, including a decline over the past month and gains over the past 3 months and longer periods. See our latest analysis for Dassault Aviation société anonyme. At a share price of €310, Dassault Aviation société anonyme has recently given back some ground, with a 30 day share price return of a 9.88% decline. This comes even though the 90 day share price...

If you are wondering whether Dassault Systèmes at €16.61 is starting to look like value, you are not alone. This article is designed to help you frame that question clearly. The stock has seen a 3.5% decline over the last 7 days, a 7.9% decline over the last 30 days, a 29.0% decline year to date, and a 53.7% decline over the last year, with a 55.3% decline over 3 years and 54.5% decline over 5 years. These sustained declines have put valuation firmly in focus for many investors, who are...

What recent performance tells you about Nanobiotix Nanobiotix (ENXTPA:NANO) has drawn fresh attention after recent price moves, with the stock showing a 1.9% gain over the past day, a small decline over the past week, and double digit returns over the past month and past 3 months. See our latest analysis for Nanobiotix. While the share price has cooled slightly over the past week, the recent 24.9% 1 month share price return sits within a much stronger backdrop. The year to date share price...

Sanofi (ENXTPA:SAN) is back in focus after Japan approved Dupixent for adults with moderate to severe bullous pemphigoid, a rare skin disease. This adds another immunology indication to its portfolio. See our latest analysis for Sanofi. News around Dupixent and other rare disease programs has coincided with a short-term lift, with a 1-day share price return of 1.36% and 7-day share price return of 3.84%, although the 1-year total shareholder return of 16.82% and 3-year total shareholder...

Voltalia (ENXTPA:VLTSA) has drawn attention after recent trading data showed negative returns over the past month and past 3 months. This has prompted investors to reassess the renewable energy producer’s value and risk profile. See our latest analysis for Voltalia. At a share price of €6.56, Voltalia’s recent 7 day and 30 day share price returns of 4.02% and 6.95% declines, alongside a 19.66% year to date decline, point to fading momentum. The 1 year total shareholder return decline of 3.67%...

If you are wondering whether BNP Paribas at €81.87 offers fair value or a potential bargain, this article explores what the current price might imply for you as a shareholder. The stock has recently seen mixed returns, with a 3.1% decline over 7 days and a 13.3% decline over 30 days, while still showing 13.1% over 1 year, 88.7% over 3 years, and 122.1% over 5 years. Recent headlines around BNP Paribas have focused on its position as a major European bank in a sector where investors are...

Amidst heightened uncertainty and inflation risks, the European market has been navigating a challenging landscape, with the STOXX Europe 600 Index recently experiencing a decline of 3.79% due to geopolitical tensions and soaring energy prices. In such an environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.

Buyback authorization sets near term context for Technip Energies shares Technip Energies (ENXTPA:TE) has put a new €150 million share repurchase program in place, covering up to 5,000,000 shares and splitting planned purchases between cancellation and equity compensation needs. See our latest analysis for Technip Energies. That buyback news lands at a time when Technip Energies’ share price has been firming up, with a 7 day share price return of 9.10% and a year to date share price return of...

Why Vallourec (ENXTPA:VK) is Back on Investor Radars Vallourec (ENXTPA:VK) has drawn fresh attention after recent share price moves, with investors weighing its €3,809 million revenue base and €355 million net income against performance over the month and past 3 months. See our latest analysis for Vallourec. The recent 1-day share price return of 1.86% builds on a 37.29% 3 month share price return, while the 5 year total shareholder return of 135.32% points to momentum that investors are now...

Event context and recent share performance Thales (ENXTPA:HO) shares have softened recently, with a 1-day return showing a 1.8% decline and a 1-month return showing a 3.8% decline, while the past 3 months show a 5.7% gain. See our latest analysis for Thales. At a share price of €241.6, Thales has seen some short term share price pressure, with the 7 day and 1 month share price returns both negative. However, the 3 month share price return and 3 year and 5 year total shareholder returns remain...

Innate Pharma (ENXTPA:IPH) has just posted its FY 2025 first half numbers, with revenue of €4.86 million and a basic EPS loss of €0.25, alongside net income excluding extra items of a €21.34 million loss. Over the last three reported halves, revenue has moved from €12.35 million in 1H 2024 to €7.78 million in 2H 2024 and €4.86 million in 1H 2025. Basic EPS losses were €0.31, €0.30 and €0.25 respectively. This provides a clearer view of how top line and per share losses have tracked as the...

This article examines whether Carrefour at €15.55 represents fair value or a potential bargain by exploring what the current price may be implying about the business. The stock has returned 1.7% over the last week, 7.9% year to date and 29.1% over the past year, while the 30-day return is a 3.6% decline and the 3- and 5-year returns are 1.1% and 28.0% respectively. Recent coverage around Carrefour has focused on the group as a major European food retailer, with investors weighing its...

Renault and its partners have completed a large scale public trial of V2X collision prevention technology in Bordeaux. The trial focused on smart mobility and safety in a live public transport setting. The consortium is now in commercial discussions to bring this V2X solution to market. For investors watching ENXTPA:RNO, this development comes with the share price at €28.17 and a mixed return profile. The stock is up 3.1% over the past week but shows declines of 13.6% over 30 days and 22.5%...